Name
Rauam & Gavronski Perearstikekus OÜ
Registry code
10351775
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
23.12.1997 (26)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
828 276 €
73 709 €
9%
2 740 €
(estimate is approximate)
293 625 €
9
Submitted
No tax arrears
25%
21%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Liivia Pullerits 27.02.1962 (62) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Mare Peda 14.04.1948 (76) | - | - | - | Founder |
| 2019 01.09.2020 | 2020 28.06.2021 | 2021 29.06.2022 | 2022 16.06.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 551 638 € | 565 288 € | 623 573 € | 705 975 € | 828 276 € |
| Net profit (loss) for the period | 69 354 € | 81 373 € | 80 477 € | 61 611 € | 73 709 € |
| Profit Margin | 13% | 14% | 13% | 9% | 9% |
| Current Assets | 178 165 € | 234 701 € | 246 789 € | 308 321 € | 350 640 € |
| Fixed Assets | 2 624 € | 2 178 € | 6 951 € | 8 590 € | 7 384 € |
| Total Assets | 180 789 € | 236 879 € | 253 740 € | 316 911 € | 358 024 € |
| Current Liabilities | 49 111 € | 53 946 € | 50 331 € | 71 885 € | 64 399 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 131 678 € | 182 933 € | 203 409 € | 245 026 € | 293 625 € |
| Employees | 8 | 8 | 9 | 9 | 9 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 40 329.99 € | 43 056.02 € | 9 |
| 2023 Q4 | - | 44 664.05 € | 42 842.02 € | 9 |
| 2023 Q3 | - | 45 261.31 € | 48 828.08 € | 11 |
| 2023 Q2 | - | 30 277.47 € | 32 575.65 € | 10 |
| 2023 Q1 | - | 45 579.05 € | 44 469.32 € | 9 |
| 2022 Q4 | - | 32 195.05 € | 34 656.64 € | 10 |
| 2022 Q3 | - | 36 521.8 € | 39 266.83 € | 10 |
| 2022 Q2 | - | 31 193.09 € | 33 641.23 € | 9 |
| 2022 Q1 | - | 37 584.99 € | 35 075.22 € | 9 |
| 2021 Q4 | - | 24 879.44 € | 26 724.22 € | 9 |
| 2021 Q3 | - | 45 785.07 € | 41 272.95 € | 9 |
| 2021 Q2 | - | 24 351.62 € | 26 158.4 € | 9 |
| 2021 Q1 | - | 35 012.44 € | 31 417.54 € | 8 |
| 2020 Q4 | - | 27 747.91 € | 29 784.1 € | 8 |
| 2020 Q3 | - | 30 679.23 € | 33 018.53 € | 8 |
| 2020 Q2 | - | 23 001.88 € | 24 897.11 € | 8 |
| 2020 Q1 | - | 31 882.91 € | 29 001.81 € | 8 |
